OMEICOS Therapeutics

Description: OMEICOS develops first-in-class small molecules using omega-3 metabolites to treat arrhythmias by activating a cardio-protective pathway, aiming for curative effects.

Country: Germany

Based in: Berlin

Founded: 2013

Funding Stage: Series A/B

Tags: ['BioTech', 'Therapeutics', 'Healthcare']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.